Skip Navigation

European Heart Journal 2003 24(12):1176; doi:10.1016/S0195-668X(03)00196-9
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brendorp, B
Right arrow Articles by Køber, L
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brendorp, B
Right arrow Articles by Køber, L
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

ERRATUM

Erratum to ‘Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval. A follow-up on the Diamond-CHF QT substudy’ [European Heart 2003;24(3):274-9]1,,2

B Brendorpa,*, C Torp-Pedersena, H Elminga and L Køberb

a Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark
b Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark

* Corresponding author: Dr B. Brendorp, Skippermosen 11,3400 Hillerod, Denmark. Tel.: +45-482-68623; fax: +45-397-51803
E-mail address: bb{at}heart.dl

The publisher regrets that the following errors occurred in the above article, which appeared in the first February issue of 2003. We apologise for any inconvenience caused by this matter.

Page 274, line 13 of abstract should read: ‘For dofetilide treated patients with a baseline QTc interval <429ms, increased mortality was observed during the extended follow-up compared to placebo (risk ratio 1.5, 95% confidence interval 1.1–2.8).’

Page 276, Table 1 (Laboratory results) should read: ‘Serum-potassium (mmoll–1). Serum-potassium (µmoll–1)’.

Page 276, Table 2should read:


View this table:
[in this window]
[in a new window]
  		Table 2 Mortality during extended follow-up according to baseline QTc interval quartiles for placebo and dofetitide treated patients

 
Page 276, line 1 of Univariate survival analysis should read: ‘Patients in the lowest baseline QTc interval quartile (<429ms) had a non-significant 35% increase in mortality risk in the dofetilide group (RR 1.35, 95% CI 0.8–2.2, p>0.2).’

Page 277, line 20 of Multivariate survival analysis should read: ‘Although the QTc interval was prolonged in the dofetilide group (26(–22/86)ms) compared to placebo (–7(–45/29)ms), no significant interaction was found between the baseline QTc interval and post-randomisation changes in the QTc interval regarding mortality (p value for interaction between the baseline QTc interval and post-randomisation QTc interval changes: dofetilide p>0.8, placebo p>0.1).’

Page 278, line 26 of Discussion should read: ‘p<0.26, QTc interval 454–479ms: 1.1(0.7–1.7),’

Footnotes

1 doi of original article 10.1016/S0195-668X(02)00427-X Back

2 For the DIAMOND study group Back


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brendorp, B
Right arrow Articles by Køber, L
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brendorp, B
Right arrow Articles by Køber, L
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?